文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Role of gut microbiota via the gut-liver-brain axis in digestive diseases.

作者信息

Ding Jian-Hong, Jin Zhe, Yang Xiao-Xu, Lou Jun, Shan Wei-Xi, Hu Yan-Xia, Du Qian, Liao Qiu-Shi, Xie Rui, Xu Jing-Yu

机构信息

Department of Gastroenterology, Affiliated Hospital to Zunyi Medical University, Zunyi 563003, Guizhou Province, China.

出版信息

World J Gastroenterol. 2020 Oct 28;26(40):6141-6162. doi: 10.3748/wjg.v26.i40.6141.


DOI:10.3748/wjg.v26.i40.6141
PMID:33177790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7596643/
Abstract

The gut-brain axis is a bidirectional information interaction system between the central nervous system (CNS) and the gastrointestinal tract, in which gut microbiota plays a key role. The gut microbiota forms a complex network with the enteric nervous system, the autonomic nervous system, and the neuroendocrine and neuroimmunity of the CNS, which is called the microbiota-gut-brain axis. Due to the close anatomical and functional interaction of the gut-liver axis, the microbiota-gut-liver-brain axis has attracted increased attention in recent years. The microbiota-gut-liver-brain axis mediates the occurrence and development of many diseases, and it offers a direction for the research of disease treatment. In this review, we mainly discuss the role of the gut microbiota in the irritable bowel syndrome, inflammatory bowel disease, functional dyspepsia, non-alcoholic fatty liver disease, alcoholic liver disease, cirrhosis and hepatic encephalopathy via the gut-liver-brain axis, and the focus is to clarify the potential mechanisms and treatment of digestive diseases based on the further understanding of the microbiota-gut- liver-brain axis.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d428/7596643/42aa505770db/WJG-26-6141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d428/7596643/42aa505770db/WJG-26-6141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d428/7596643/42aa505770db/WJG-26-6141-g001.jpg

相似文献

[1]
Role of gut microbiota via the gut-liver-brain axis in digestive diseases.

World J Gastroenterol. 2020-10-28

[2]
Irritable bowel syndrome, the microbiota and the gut-brain axis.

Gut Microbes. 2016-9-2

[3]
The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions.

Eur J Intern Med. 2021-2

[4]
Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders.

Nutrients. 2021-1-27

[5]
Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis.

Prog Neuropsychopharmacol Biol Psychiatry. 2021-4-20

[6]
Irritable Bowel Syndrome and Stress-Related Psychiatric Co-morbidities: Focus on Early Life Stress.

Handb Exp Pharmacol. 2017

[7]
Microbiota-gut-brain axis: enteroendocrine cells and the enteric nervous system form an interface between the microbiota and the central nervous system.

Biomed Res. 2020

[8]
Targeting the gut-microbiota-brain axis in irritable bowel disease to improve cognitive function - recent knowledge and emerging therapeutic opportunities.

Rev Neurosci. 2023-10-26

[9]
The gut-brain axis in irritable bowel syndrome and inflammatory bowel disease.

Dig Liver Dis. 2021-3

[10]
"Sentinel or accomplice": gut microbiota and microglia crosstalk in disorders of gut-brain interaction.

Protein Cell. 2023-10-25

引用本文的文献

[1]
Bacterial Extracellular Vesicles: Emerging Regulators in the Gut-Organ Axis and Prospective Biomedical Applications.

Curr Microbiol. 2025-9-1

[2]
Intestinal ischemia-reperfusion and blood-brain barrier compromise: pathways to cognitive dysfunction.

Front Neurosci. 2025-7-15

[3]
Effects of Stems and Leaves of on mRNA Expression of TLR Signaling Pathway in Hepatic Tissue of Duzang Pigs.

Genes (Basel). 2025-6-30

[4]
Causal relationship between gut microbiota and hepatocellular carcinoma: a two-sample Mendelian randomization and case-control study.

Discov Oncol. 2025-6-3

[5]
The Microbiota-Gut-Brain Axis: Key Mechanisms Driving Glymphopathy and Cerebral Small Vessel Disease.

Life (Basel). 2024-12-24

[6]
Modulation of Intestinal Inflammation and Protection of Dopaminergic Neurons in Parkinson's Disease Mice through a Probiotic Formulation Targeting NLRP3 Inflammasome.

J Neuroimmune Pharmacol. 2025-1-18

[7]
Mucosal immune response in biology, disease prevention and treatment.

Signal Transduct Target Ther. 2025-1-8

[8]
Gut‑liver axis in liver disease: From basic science to clinical treatment (Review).

Mol Med Rep. 2025-1

[9]
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis.

Front Pharmacol. 2024-10-9

[10]
Gut Bacteria in Alcohol-Associated Liver Disease.

Clin Liver Dis. 2024-11

本文引用的文献

[1]
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.

Am J Gastroenterol. 2020-7

[2]
Role of Gut Microbiota in Neuroendocrine Regulation of Carbohydrate and Lipid Metabolism via the Microbiota-Gut-Brain-Liver Axis.

Microorganisms. 2020-4-7

[3]
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients.

Antibiotics (Basel). 2020-3-29

[4]
Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.

Gastroenterology. 2020-8

[5]
Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis.

J Hepatol. 2020-5

[6]
Bacterial toxin linked to severe alcoholic liver disease.

Science. 2019-11-15

[7]
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.

Nature. 2019-11-13

[8]
Increasing Burden of Acute-On-Chronic Liver Failure Among Alcohol-Associated Liver Disease in the Young Population in the United States.

Am J Gastroenterol. 2020-1

[9]
The gut-liver axis in liver disease: Pathophysiological basis for therapy.

J Hepatol. 2020-3

[10]
The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease.

J Hepatol. 2020-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索